BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35359970)

  • 1. Systematic Analysis of Neurotransmitter Receptors in Human Breast Cancer Reveals a Strong Association With Outcome and Uncovers HTR6 as a Survival-Associated Gene Potentially Regulating the Immune Microenvironment.
    Zhang W; Li L; Li J; Yu H; Zheng F; Yan B; Cai W; Chen Y; Yin L; Tang D; Xu Y; Dai Y
    Front Immunol; 2022; 13():756928. PubMed ID: 35359970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-Omics Analyses Revealed GOLT1B as a Potential Prognostic Gene in Breast Cancer Probably Regulating the Immune Microenvironment.
    Liu J; Zhang W; Cai W; Chen Y; Cai X; Tang D; Tang M; Dai Y
    Front Oncol; 2021; 11():805273. PubMed ID: 35127514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor intrinsic subtype is reflected in cancer-adjacent tissue.
    Casbas-Hernandez P; Sun X; Roman-Perez E; D'Arcy M; Sandhu R; Hishida A; McNaughton KK; Yang XR; Makowski L; Sherman ME; Figueroa JD; Troester MA
    Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):406-14. PubMed ID: 25465802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated computer analysis and a self-built Chinese cohort study identified GSTM2 as one survival-relevant gene in human colon cancer potentially regulating immune microenvironment.
    Zhang W; Shi Y; Niu S; Li L; Lin L; Gao X; Cai W; Chen Y; Zhong Y; Tang D; Tang M; Dai Y
    Front Oncol; 2022; 12():881906. PubMed ID: 36263204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients.
    Román-Pérez E; Casbas-Hernández P; Pirone JR; Rein J; Carey LA; Lubet RA; Mani SA; Amos KD; Troester MA
    Breast Cancer Res; 2012 Mar; 14(2):R51. PubMed ID: 22429463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Immune and Stroma Related Prognostic Marker for Invasive Breast Cancer in Tumor Microenvironment: A TCGA Based Study.
    Huang Y; Chen L; Tang Z; Min Y; Yu W; Yang G; Zhang L
    Front Endocrinol (Lausanne); 2021; 12():774244. PubMed ID: 34867821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRAF/MEK Pathway is Associated With Breast Cancer in ER-dependent Mode and Improves ER Status-based Cancer Recurrence Prediction.
    Liu D; Zhou K
    Clin Breast Cancer; 2020 Feb; 20(1):41-50.e8. PubMed ID: 31547956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel immune-related prognostic index for predicting breast cancer overall survival.
    Yu X; Guo J; Zhou Q; Huang W; Xu C; Long X
    Breast Cancer; 2021 Mar; 28(2):434-447. PubMed ID: 33146847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of HLA-G/KIR2DL4 in Breast Cancer Immune Microenvironment.
    Zheng G; Jia L; Yang AG
    Front Immunol; 2022; 13():791975. PubMed ID: 35185887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of the Immune/Methylation/Autophagy Landscape on Single-Cell Genotypes and Stroke Risk in Breast Cancer Microenvironment.
    Wu JY; Qin J; Li L; Zhang KD; Chen YS; Li Y; Jin T; Xu JM
    Oxid Med Cell Longev; 2021; 2021():5633514. PubMed ID: 34457116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel immune-related genes in the tumor microenvironment with prognostic value in breast cancer.
    Tan W; Liu M; Wang L; Guo Y; Wei C; Zhang S; Luo C; Liu N
    BMC Cancer; 2021 Feb; 21(1):126. PubMed ID: 33549054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.
    Pelekanou V; Villarroel-Espindola F; Schalper KA; Pusztai L; Rimm DL
    Breast Cancer Res; 2018 Dec; 20(1):154. PubMed ID: 30558648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence.
    Caruso JA; Karakas C; Zhang J; Yi M; Albarracin C; Sahin A; Bondy M; Liu J; Hunt KK; Keyomarsi K
    Breast Cancer Res; 2014; 16(6):3417. PubMed ID: 25551582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of lipid metabolism dysregulation and the effects on immune microenvironments in pan-cancer using multiple omics data.
    Hao Y; Li D; Xu Y; Ouyang J; Wang Y; Zhang Y; Li B; Xie L; Qin G
    BMC Bioinformatics; 2019 May; 20(Suppl 7):195. PubMed ID: 31074374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of beclin-1 in the microenvironment of invasive ductal carcinoma of the breast: correlation with prognosis and the cancer-stromal interaction.
    Morikawa A; Takeuchi T; Kito Y; Saigo C; Sakuratani T; Futamura M; Yoshida K
    PLoS One; 2015; 10(5):e0125762. PubMed ID: 25955408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of B7-H3, a potential factor of tumor immune evasion in combination with the number of regulatory T cells, affects against recurrence-free survival in breast cancer patients.
    Maeda N; Yoshimura K; Yamamoto S; Kuramasu A; Inoue M; Suzuki N; Watanabe Y; Maeda Y; Kamei R; Tsunedomi R; Shindo Y; Inui M; Tamada K; Yoshino S; Hazama S; Oka M
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4(Suppl 4):S546-54. PubMed ID: 24562936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host genotype and tumor phenotype of chemokine decoy receptors integrally affect breast cancer relapse.
    Yu KD; Wang X; Yang C; Zeng XH; Shao ZM
    Oncotarget; 2015 Sep; 6(28):26519-27. PubMed ID: 26314842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of invasive breast cancer samples using a 12-chemokine gene expression score: correlation with clinical outcomes.
    Prabhakaran S; Rizk VT; Ma Z; Cheng CH; Berglund AE; Coppola D; Khalil F; Mulé JJ; Soliman HH
    Breast Cancer Res; 2017 Jun; 19(1):71. PubMed ID: 28629479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic Analysis Uncovers Associations of PGK1 with Prognosis and Immunological Characteristics in Breast Cancer.
    Li L; Bai Y; Gao Y; Li D; Chen L; Zhou C; Feng M; Chen X; Jin W; Cao Y
    Dis Markers; 2021; 2021():7711151. PubMed ID: 34790279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
    De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
    Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.